Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells

Journal of Molecular and Cellular Cardiology

Volumn 46, Issue 6, 2009, Pages 867-875

  Katragadda, D ^a   Batchu, S N ^a   Cho, W J ^a   Chaudhary, K R ^a   Falck, J R ^b   Seubert, J M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Arachidonic acid; Cytochrome P450; Eicosanoid; Ischemia reperfusion; K+ channel; Mitochondria

Indexed keywords

14,15 EPOXY 5,8,11 ICOSATRIENOIC ACID; 14,15 EPOXYEICOSA 5 ENOIC ACID; ARACHIDONIC ACID; ATRACTYLOSIDE; CYTOCHROME P450 2J2; EPOXIDE HYDROLASE; EPOXYICOSATRIENOIC ACID; PAXILLINE; POLYUNSATURATED FATTY ACID; POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRESS; CONTROLLED STUDY; EPHX2 GENE; FATTY ACID SYNTHESIS; GENE; GENE DISRUPTION; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSVERSE TUBULAR SYSTEM;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ANTIMUTAGENIC AGENTS; CELL LINE; CELLS, CULTURED; COBALT; CYTOCHROME P-450 ENZYME SYSTEM; EPOXIDE HYDROLASES; FLUORESCEINS; HUMANS; INDICATORS AND REAGENTS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

MUS; RATTUS;

EID: 67349123094     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.02.028     Document Type: Article

References (54)

1. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82 1 (2002) 131-185
2. Fang X., Weintraub N.L., McCaw R.B., Hu S., Harmon S.D., Rice J.B., et al. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. Am. J. Physiol. Heart Circ. Physiol. 287 6 (2004) H2412-H2420
3. Saluja I., Song D., O'Regan M.H., and Phillis J.W. Role of phospholipase A2 in the release of free fatty acids during ischemia-reperfusion in the rat cerebral cortex. Neurosci. Lett. 233 2-3 (1997) 97-100
4. Newman J.W., Morisseau C., and Hammock B.D. Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog. Lipid Res. 44 1 (2005) 1-51
5. Ussher J.R., and Lopaschuk G.D. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc. Res. 79 2 (2008) 259-268
6. Stanley W.C., Morgan E.E., Huang H., McElfresh T.A., Sterk J.P., Okere I.C., et al. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia. Am. J. Physiol. Heart Circ. Physiol. 289 6 (2005) H2304-H2309
7. Ferdinandy P., Schulz R., and Baxter G.F. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol. Rev. 59 4 (2007) 418-458
8. Halestrap A.P. Mitochondrial permeability: dual role for the ADP/ATP translocator?. Nature 430 7003 (2004) 1 p following 983
9. Murphy E., and Steenbergen C. Ion transport and energetics during cell death and protection. Physiology (Bethesda). 23 (2008) 115-123
10. Aon M.A., O'Rourke B., and Cortassa S. The fractal architecture of cytoplasmic organization: scaling, kinetics and emergence in metabolic networks. Mol. Cell. Biochem. 256-257 1-2 (2004) 169-184
11. Hausenloy D.J., and Yellon D.M. Time to take myocardial reperfusion injury seriously. N. Engl. J. Med. 359 5 (2008) 518-520
12. Bose A.K., Mocanu M.M., Carr R.D., and Yellon D.M. Myocardial ischaemia-reperfusion injury is attenuated by intact glucagon like peptide-1 (GLP-1) in the in vitro rat heart and may involve the p70s6K pathway. Cardiovasc. Drugs Ther. 21 4 (2007) 253-256
13. Murphy E. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ. Res. 94 1 (2004) 7-16
14. Seubert J., Yang B., Bradbury J.A., Graves J., Degraff L.M., and Gabel S. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway. Circ. Res. 95 5 (2004) 506-514
15. Nithipatikom K., Moore J.M., Isbell M.A., Falck J.R., and Gross G.J. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 291 2 (2006) H537-H542
16. Zhang W., Otsuka T., Sugo N., Ardeshiri A., Alhadid Y.K., Iliff J.J., et al. Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia. Stroke 39 7 (2008) 2073-2078
17. Dhanasekaran A., Gruenloh S.K., Buonaccorsi J.N., Zhang R., Gross G.J., Falck J.R., et al. Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia. Am. J. Physiol. Heart Circ. Physiol. 294 2 (2008) H724-H735
18. Gross G.J., and Peart J.N. KATP channels and myocardial preconditioning: an update. Am. J. Physiol. Heart Circ. Physiol. 285 3 (2003) H921-H930
19. Gross G.J., and Fryer R.M. Sarcolemmal versus mitochondrial ATP-sensitive K+ channels and myocardial preconditioning. Circ. Res. 84 9 (1999) 973-979
20. Calderone V. Large-conductance, ca(2+)-activated k(+) channels: function, pharmacology and drugs. Curr. Med. Chem. 9 14 (2002) 1385-1395
21. Hanley P.J., and Daut J. K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms. J. Mol. Cell. Cardiol. 39 1 (2005) 17-50
22. Xu W., Liu Y., Wang S., McDonald T., Van Eyk J.E., Sidor A., et al. Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane. Science 298 5595 (2002) 1029-1033
23. Cho W.J., Chow A.K., Schulz R., and Daniel E.E. Matrix metalloproteinase-2, caveolins, focal adhesion kinase and c-Kit in cells of the mouse myocardium. J. Cell. Mol. Med. 11 5 (2007) 1069-1086
24. Hausenloy D.J., Duchen M.R., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc. Res. 60 3 (2003) 617-625
25. Petronilli V., Miotto G., Canton M., Brini M., Colonna R., Bernardi P., et al. Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76 2 (1999) 725-734
26. Seubert J.M., Sinal C.J., Graves J., DeGraff L.M., Bradbury J.A., Lee C.R., et al. Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function. Circ. Res. 99 4 (2006) 442-450
27. Lu T., Ye D., Wang X., Seubert J.M., Graves J.P., Bradbury J.A., et al. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms. J. Physiol. 575 Pt 2 (2006) 627-644
28. Huser J., and Blatter L.A. Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem. J. 343 Pt 2 (1999) 311-317
29. Duchen M.R. Mitochondria and Ca(2+)in cell physiology and pathophysiology. Cell Calcium 28 5-6 (2000) 339-348
30. De Giorgi F., Lartigue L., Bauer M.K., Schubert A., Grimm S., Hanson G.T., et al. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J. 16 6 (2002) 607-609
31. Hausenloy D., Wynne A., Duchen M., and Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation 109 14 (2004) 1714-1717
32. Motoki A., Merkel M.J., Packwood W.H., Cao Z., Liu L., Iliff J., et al. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo. Am. J. Physiol. Heart Circ. Physiol. 295 5 (2008) H2128-H2134
33. Maack C., and O'Rourke B. Excitation-contraction coupling and mitochondrial energetics. Basic Res. Cardiol. 102 5 (2007) 369-392
34. Jendrach M., Mai S., Pohl S., Voth M., and Bereiter-Hahn J. Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion 8 4 (2008) 293-304
35. Karbowski M., Lee Y.J., Gaume B., Jeong S.Y., Frank S., Nechushtan A., et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 159 6 (2002) 931-938
36. Skulachev V.P., Bakeeva L.E., Chernyak B.V., Domnina L.V., Minin A.A., Pletjushkina O.Y., et al. Thread-grain transition of mitochondrial reticulum as a step of mitoptosis and apoptosis. Mol. Cell. Biochem. 256-257 1-2 (2004) 341-358
37. Brady N.R., Hamacher-Brady A., and Gottlieb R.A. Proapoptotic BCL-2 family members and mitochondrial dysfunction during ischemia/reperfusion injury, a study employing cardiac HL-1 cells and GFP biosensors. Biochim. Biophys. Acta 1757 5-6 (2006) 667-678
38. Bereiter-Hahn J., Voth M., Mai S., and Jendrach M. Structural implications of mitochondrial dynamics. Biotechnol. J. 3 6 (2008) 765-780
39. Hauptmann S., Scherping I., Drose S., Brandt U., Schulz K.L., Jendrach M., et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol. Aging (2008)
40. Youle R.J., and Karbowski M. Mitochondrial fission in apoptosis. Nat. Rev., Mol. Cell Biol. 6 8 (2005) 657-663
41. Cannell M.B., Crossman D.J., and Soeller C. Effect of changes in action potential spike configuration, junctional sarcoplasmic reticulum micro-architecture and altered t-tubule structure in human heart failure. J. Muscle Res. Cell Motil. 27 5-7 (2006) 297-306
42. He J., Conklin M.W., Foell J.D., Wolff M.R., Haworth R.A., Coronado R., et al. Reduction in density of transverse tubules and L-type Ca(2+) channels in canine tachycardia-induced heart failure. Cardiovasc. Res. 49 2 (2001) 298-307
43. Brette F., and Orchard C. Resurgence of cardiac t-tubule research. Physiology (Bethesda). 22 (2007) 167-173
44. Ke Q., Xiao Y.F., Bradbury J.A., Graves J.P., Degraff L.M., Seubert J.M., et al. Electrophysiological properties of cardiomyocytes isolated from CYP2J2 transgenic mice. Mol. Pharmacol. 72 4 (2007) 1063-1073
45. Xiao Y.F., Ke Q., Seubert J.M., Bradbury J.A., Graves J., Degraff L.M., et al. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2. Mol. Pharmacol. 66 6 (2004) 1607-1616
46. Larsen B.T., Gutterman D.D., and Hatoum O.A. Emerging role of epoxyeicosatrienoic acids in coronary vascular function. Eur. J. Clin. Invest. 36 5 (2006) 293-300
47. Buckman J.F., and Reynolds I.J. Spontaneous changes in mitochondrial membrane potential in cultured neurons. J. Neurosci. 21 14 (2001) 5054-5065
48. Duchen M.R., Leyssens A., and Crompton M. Transient mitochondrial depolarizations reflect focal sarcoplasmic reticular calcium release in single rat cardiomyocytes. J. Cell Biol. 142 4 (1998) 975-988
49. Halestrap A.P., Clarke S.J., and Javadov S.A. Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc. Res. 61 3 (2004) 372-385
50. Hausenloy D.J., Maddock H.L., Baxter G.F., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc. Res. 55 3 (2002) 534-543
51. O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ. Res. 94 4 (2004) 420-432
52. Wickenden A. K(+) channels as therapeutic drug targets. Pharmacol. Ther. 94 1-2 (2002) 157-182
53. Batchu S.N., Law E., Brocks D.R., Falck J.R., and Seubert J.M. Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model. J. Mol. Cell. Cardiol. 46 1 (2009) 67-74
54. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem. J. 341 Pt 2 (1999) 233-249